The CME CF Bitcoin Reference Rate - New York Variant (BRRNY) is a once a day benchmark index price for Bitcoin that aggregates trade data from multiple Bitcoin-USD markets operated by major cryptocurrency exchanges that conform to the CME CF Constituent Exchange Criteria. It is the pre-eminent index price for Bitcoin risk settlement that is synchronized to the traditional US financial market close of 1600 New York Time. The Index is a Registered Benchmark under UK BMR and as such is a Third Country benchmark under the EU BMR Regime.
Watch our video here
For additional information, please visit:
https://www.cfbenchmarks.com/data/indices/BRRNY
The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell any of the underlying instruments cited including but not limited to cryptoassets, financial instruments or any instruments that reference any index provided by CF Benchmarks Ltd. This communication is not intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. Please contact your financial adviser or professional before making an investment decision.
Note: Some of the underlying instruments cited within this material may be restricted to certain customer categories in certain jurisdictions.
The Administrator has confirmed changes to the Token Market Price Family for the period 04 August 2026 to 11 August 2026.

CF Benchmarks
Digital assets edged higher throughout the week as volatility approached a 52-week low. Breadth remained narrow, leadership shifted toward smaller-cap names, and stress stayed largely idiosyncratic, even as Bitcoin funding rates spiked amid easing dollar conditions.

Mark Pilipczuk
The Administrator announces the amendment of the Potentially Erroneous Data Parameter for Certain CF Digital Asset Index Family Benchmarks

CF Benchmarks
By clicking Accept, you consent to CF Benchmarks's use of cookies.
Visit Cookie Settings to learn how CF Benchmarks uses cookies and to adjust your preferences.